Drug Enforcement Administration

65 Federal Register documents from Drug Enforcement Administration, last 60 days.

  1. Specific Listing for 3-Chloromethcathinone, A Currently Controlled Schedule I Substance

    Rule · published 2026-11-06 · effective 2026-11-06 · Docket No. DEA-1768
    Drug Enforcement Administration, Justice Department · 2026-22717

    The Drug Enforcement Administration (DEA) is establishing a specific listing and DEA Controlled Substances Code Number (drug code) for 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3- chloromethcathinone; 3-CMC) in schedule I of the Controlled Substances Act (CSA). Although 3-chloromethcathinone is not specifically ...

  2. Bulk Manufacturer of Controlled Substances Application: Navinta LLC

    Notice · published 2026-11-05 · comments close 2027-01-04 · Docket No. DEA-1796
    Drug Enforcement Administration, Justice Department · 2026-22556

    Navinta LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

  3. Importer of Controlled Substances Application: Diamond Animal Health, Inc.

    Notice · published 2026-11-05 · comments close 2026-12-07 · Docket No. DEA-1795
    Drug Enforcement Administration, Justice Department · 2026-22555

    Diamond Animal Health, Inc., has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

  4. Importer of Controlled Substances Application: Noramco

    Notice · published 2026-11-05 · comments close 2026-12-07 · Docket No. DEA-1791
    Drug Enforcement Administration, Justice Department · 2026-22553

    Noramco has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

  5. Technical Amendment to the Regulation Regarding Amendments to Applications

    Rule · published 2026-11-04 · effective 2026-11-04 · Docket No. DEA-1303
    Drug Enforcement Administration, Justice Department · 2026-22484

    This final rule updates a Drug Enforcement Administration regulation to clarify that the provision regarding amendments to and withdrawal of registration applications also applies to applications for registration renewal. This action makes no substantive changes to this regulation.

  6. Bulk Manufacturer of Controlled Substances Application: AJNA Biosciences

    Notice · published 2026-11-02 · comments close 2027-01-04 · Docket No. 1793
    Drug Enforcement Administration, Justice Department · 2026-22289

    AJNA Biosciences has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

  7. Importer of Controlled Substances Application: Globyz Pharma LLC

    Notice · published 2026-11-02 · comments close 2026-12-02 · Docket No. DEA-1792
    Drug Enforcement Administration, Justice Department · 2026-22288

    Globyz Pharma LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

  8. Conforming Amendment Regarding the Criminal Law Technical Amendments Act of 2002

    Rule · published 2026-11-02 · effective 2026-11-02 · Docket No. DEA-1302
    Drug Enforcement Administration, Justice Department · 2026-22285

    The Criminal Law Technical Amendments Act of 2002 ("Technical Amendments Act") became law on November 2, 2002, as part of the 21st Century Department of Justice Appropriations Authorization Act. The Technical Amendments Act amended sections 401(d), 402(c), and 403 of the Controlled Substances Act by replacing outmoded ...

  9. Schedules of Controlled Substances: Placement of Centanafadine in Schedule III

    Rule · published 2026-10-30 · comments close 2026-11-30 · effective 2026-10-30 · Docket No. DEA-1743
    Drug Enforcement Administration, Justice Department · 2026-22208

    On July 24, 2026, the United States Food and Drug Administration (FDA) approved a new drug application for Simtriyo (centanafadine) for the treatment of attention-deficit/hyperactivity disorder in adults and pediatric patients aged 6 years and older, weighing at least 20 kg. The Department of Health and Human Services ...

  10. Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc.

    Notice · published 2026-10-29 · comments close 2026-12-28 · Docket No. DEA-1776
    Drug Enforcement Administration, Justice Department · 2026-22048

    Sigma Aldrich Research Biochemicals, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

  11. Vida Janson, M.D.; Decision and Order

    Notice · published 2026-10-26 · Docket No. 26-112
    Drug Enforcement Administration, Justice Department · 2026-21799

  12. Barry Backiewicz, D.D.S.; Decision and Order

    Notice · published 2026-10-26
    Drug Enforcement Administration, Justice Department · 2026-21725

  13. Peter Michael Wills, D.D.S.; Decision and Order

    Notice · published 2026-10-20
    Drug Enforcement Administration, Justice Department · 2026-21415

  14. Jan Pijanowski, M.D.; Decision and Order

    Notice · published 2026-10-20
    Drug Enforcement Administration, Justice Department · 2026-21414

  15. Jefferson Burroughs, M.D.; Decision and Order

    Notice · published 2026-10-20
    Drug Enforcement Administration, Justice Department · 2026-21413

  16. Youmna Abdulhadi, M.D.; Decision and Order

    Notice · published 2026-10-20
    Drug Enforcement Administration, Justice Department · 2026-21410

  17. Importer of Controlled Substances Application: Organic Standards Solutions International, LLC

    Notice · published 2026-10-19 · comments close 2026-11-18 · Docket No. DEA-1789
    Drug Enforcement Administration, Justice Department · 2026-21370

    Organic Standards Solutions International, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

  18. Bulk Manufacturer of Controlled Substances Application: Janssen Pharmaceuticals, Inc.

    Notice · published 2026-10-19 · comments close 2026-12-18 · Docket No. DEA-1788
    Drug Enforcement Administration, Justice Department · 2026-21369

    Janssen Pharmaceuticals, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

  19. Bulk Manufacturer of Controlled Substances Application: Groff Health Inc

    Notice · published 2026-10-19 · comments close 2026-12-18 · Docket No. 1785
    Drug Enforcement Administration, Justice Department · 2026-21368

    Groff Health Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

  20. Importer of Controlled Substances Application: Groff NA Hemplex LLC

    Notice · published 2026-10-19 · comments close 2026-11-18 · Docket No. DEA-1790
    Drug Enforcement Administration, Justice Department · 2026-21367

    Groff NA Hemplex LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

  21. Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute

    Notice · published 2026-10-19 · comments close 2026-12-18 · Docket No. DEA-1784
    Drug Enforcement Administration, Justice Department · 2026-21360

    Scottsdale Research Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

  22. Bulk Manufacturer of Controlled Substances Application: National Center for Natural Products Research University of Mississippi/NCNPR

    Notice · published 2026-10-19 · comments close 2026-12-18 · Docket No. DEA-1783
    Drug Enforcement Administration, Justice Department · 2026-21359

    National Center for Natural Products Research University of Mississippi/NCNPR has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

  23. Importer of Controlled Substances Application: National Center for Natural Products Research

    Notice · published 2026-10-19 · comments close 2026-11-18 · Docket No. DEA-1782
    Drug Enforcement Administration, Justice Department · 2026-21358

    National Center for Natural Products Research has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

  24. Importer of Controlled Substances Application: Groff Health Inc.

    Notice · published 2026-10-19 · comments close 2026-11-18 · Docket No. DEA-1781
    Drug Enforcement Administration, Justice Department · 2026-21355

    Groff Health Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

  25. Importer of Controlled Substances Application: DMS Pharmaceutical Group

    Notice · published 2026-10-19 · comments close 2026-11-18 · Docket No. DEA-1780
    Drug Enforcement Administration, Justice Department · 2026-21354

    DMS Pharmaceutical Group has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

  26. Importer of Controlled Substances Application: Halo Pharmaceutical Inc.

    Notice · published 2026-10-19 · comments close 2026-11-18 · Docket No. DEA-1779
    Drug Enforcement Administration, Justice Department · 2026-21353

    Halo Pharmaceutical Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

  27. Muhamad Aly Rifai, M.D.; Decision and Order

    Notice · published 2026-10-19
    Drug Enforcement Administration, Justice Department · 2026-21258

  28. Schedules of Controlled Substances: Temporary Placement of 7- Hydroxymitragynine and Mitragynine Pseudoindoxyl Above a Specified Threshold in Schedule I

    Proposed Rule · published 2026-10-14 · Docket No. DEA-1570
    Drug Enforcement Administration, Justice Department · 2026-20943

    The Administrator of the Drug Enforcement Administration (DEA) is issuing this notice of intent to publish a temporary order to schedule 7-hydroxymitragynine and mitragynine pseudoindoxyl (including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, ...

  29. Schedules of Controlled Substances: Temporary Placement of MGM-15 and MGM-16 in Schedule I

    Proposed Rule · published 2026-10-14 · Docket No. DEA-1644
    Drug Enforcement Administration, Justice Department · 2026-20942

    The Drug Enforcement Administration (DEA) is issuing this notice of intent to publish a temporary order to schedule two 7- hydroxymitragynine-related substances (MGM-15 and MGM-16), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ...

  30. Katherine Curtis, N.P.; Decision and Order

    Notice · published 2026-10-14
    Drug Enforcement Administration, Justice Department · 2026-20937

  31. Schedules of Controlled Substances; Removal of Exemption Status for Inactive Butalbital Products

    Rule · published 2026-10-09 · effective 2026-11-09 · Docket No. DEA-1664
    Drug Enforcement Administration, Justice Department · 2026-20757

    The Drug Enforcement Administration (DEA) is revoking the exempted status for certain nonnarcotic prescription products that are currently on DEA's Table of Exempted Prescription Products, but whose National Drug Codes (NDC) are inactive because they are no longer available and/or the company that applied for the ...

  32. Alexandra R. Lovec, A.P.R.N.; Decision and Order

    Notice · published 2026-10-09
    Drug Enforcement Administration, Justice Department · 2026-20751

  33. L Krenk DBA Maui Clinic Pharmacy; Decision and Order

    Notice · published 2026-10-09
    Drug Enforcement Administration, Justice Department · 2026-20750

  34. Vladimir Romaniv, P.A.; Decision and Order

    Notice · published 2026-10-09
    Drug Enforcement Administration, Justice Department · 2026-20749

  35. Schedules of Controlled Substances: Placement of O-Desmethyltramadol in Schedule I; Correction

    Rule · published 2026-10-09 · effective 2026-10-09 · Docket No. DEA-1641
    Drug Enforcement Administration, Justice Department · 2026-20748

    On August 12, 2026, the Drug Enforcement Administration (DEA) published a temporary order placing O-desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2-[(dimethylamino)methyl]-1- hydroxycyclohexyl]phenol), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, ...

  36. Decision and Order: Medpharm Research, LLC

    Notice · published 2026-10-07
    Drug Enforcement Administration, Justice Department · 2026-20553

  37. Wellwise Pharmacy Inc.; Decision and Order

    Notice · published 2026-10-07
    Drug Enforcement Administration, Justice Department · 2026-20552

  38. Arenbii Pharmacy LLC; Decision and Order

    Notice · published 2026-10-07
    Drug Enforcement Administration, Justice Department · 2026-20535

  39. Mark Allen, D.D.S.; Correction to Rescission of Final Agency Action and Withdrawal of Order To Show Cause

    Notice · published 2026-10-07
    Drug Enforcement Administration, Justice Department · 2026-20533

  40. St. Michael's Pharmacy; Decision and Order

    Notice · published 2026-10-02
    Drug Enforcement Administration, Justice Department · 2026-20227

  41. By Grace Inc. Counseling Services; Decision and Order

    Notice · published 2026-10-02
    Drug Enforcement Administration, Justice Department · 2026-20226

  42. Extension of Reexportation Period.

    Proposed Rule · published 2026-10-01 · comments close 2026-11-30 · Docket No. DEA-730
    Drug Enforcement Administration, Justice Department · 2026-20084

    This proposed rule would amend the regulations of the Drug Enforcement Administration (DEA) to extend the time allowed for reexports of controlled substances outside of the European Economic Area from 180 days from the date of original release from U.S. Customs and Border Protection to 365 days from that original ...

  43. Angela Turner-Brown, N.P.; Decision and Order

    Notice · published 2026-09-29
    Drug Enforcement Administration, Justice Department · 2026-19844

  44. JT Medical, LLC; Decision and Order

    Notice · published 2026-09-29
    Drug Enforcement Administration, Justice Department · 2026-19842

  45. Christopher Nadorff, M.D.; Decision and Order

    Notice · published 2026-09-29
    Drug Enforcement Administration, Justice Department · 2026-19840

  46. Jorge J. Figueroa, M.D.; Decision and Order

    Notice · published 2026-09-29
    Drug Enforcement Administration, Justice Department · 2026-19839

  47. Johann Farley, M.D.; Decision and Order

    Notice · published 2026-09-29 · Docket No. 25-73
    Drug Enforcement Administration, Justice Department · 2026-19821

  48. Bulk Manufacturer of Controlled Substances Application: Irvine Labs, Inc.

    Notice · published 2026-09-28 · comments close 2026-11-27 · Docket No. DEA-1778
    Drug Enforcement Administration, Justice Department · 2026-19803

    Irvine Labs, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

  49. Bulk Manufacturer of Controlled Substances Application: Cargill, Incorporated

    Notice · published 2026-09-28 · comments close 2026-11-27 · Docket No. DEA-1777
    Drug Enforcement Administration, Justice Department · 2026-19795

    Cargill, Incorporated has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

  50. Importer of Controlled Substances Application: Benuvia Operations, LLC

    Notice · published 2026-09-28 · comments close 2026-10-28 · Docket No. DEA-1767
    Drug Enforcement Administration, Justice Department · 2026-19792

    Benuvia Operations, LLC. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

  51. Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company

    Notice · published 2026-09-24 · comments close 2026-11-23 · Docket No. DEA-1774
    Drug Enforcement Administration, Justice Department · 2026-19542

    Cayman Chemical Company has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

  52. Bulk Manufacturer of Controlled Substances Application: Eli-Elsohly Laboratories

    Notice · published 2026-09-24 · comments close 2026-11-23 · Docket No. DEA-1773
    Drug Enforcement Administration, Justice Department · 2026-19541

    Eli-Elsohly Laboratories has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

  53. Importer of Controlled Substances Application: Fisher Clinical Services, Inc. (I)

    Notice · published 2026-09-24 · comments close 2026-10-26 · Docket No. DEA-1772
    Drug Enforcement Administration, Justice Department · 2026-19540

    Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

  54. Importer of Controlled Substances Application: Cambridge Isotope Laboratories, Inc.

    Notice · published 2026-09-24 · comments close 2026-10-26 · Docket No. DEA-1770
    Drug Enforcement Administration, Justice Department · 2026-19539

    Cambridge Isotope Laboratories, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

  55. Bulk Manufacturer of Controlled Substances Application: Cambridge Isotope Laboratories, Inc.

    Notice · published 2026-09-24 · comments close 2026-12-23 · Docket No. DEA-1771
    Drug Enforcement Administration, Justice Department · 2026-19538

    Cambridge Isotope Laboratories, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

  56. Schedules of Controlled Substances: Placement of 4-Hydroxy-N,N-Diisopropyltryptamine (4-OH-DiPT), 5-Methoxy-alpha-Methyltryptamine (5-MeO-AMT), 5-Methoxy-N-Methyl-N-Isopropyltryptamine (5-MeO-MiPT), 5-Methoxy-N,N-Diethyltryptamine (5-MeO-DET), and N,N-Diisopropyltryptamine (DiPT) Into Schedule I

    Proposed Rule · published 2026-09-23 · comments close 2026-10-23 · Docket No. DEA1715
    Drug Enforcement Administration, Justice Department · 2026-19400

    The Drug Enforcement Administration proposes placing five tryptamine hallucinogens, 4-hydroxy-N,N-diisopropyltryptamine (other names: 4-OH-DiPT; 3-(2-(diisopropylamino)ethyl)-1H-indol-4- ol), 5-methoxy-alpha-methyltryptamine (other names: 5-MeO-AMT; 1-(5- methoxy-1H-indol-3-yl)propan-2-amine), 5-methoxy-N-methyl-N- ...

  57. Esther Villanueva Valdes, M.D.; Decision and Order

    Notice · published 2026-09-21
    Drug Enforcement Administration, Justice Department · 2026-19232

  58. Schedules of Controlled Substances: Placement of Diphenidine in Schedule I

    Rule · published 2026-09-21 · effective 2026-10-21 · Docket No. DEA-1155
    Drug Enforcement Administration, Justice Department · 2026-19231

    With the issuance of this final rule, the Drug Enforcement Administration places the substance diphenidine (1-(1,2- diphenylethyl)piperidine), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances ...

  59. John Ramsay Walters, M.D.; Decision and Order

    Notice · published 2026-09-21
    Drug Enforcement Administration, Justice Department · 2026-19230

  60. Importer of Controlled Substances Application: Irvine Labs, Inc.

    Notice · published 2026-09-14 · comments close 2026-10-14 · Docket No. DEA-1763
    Drug Enforcement Administration, Justice Department · 2026-18757

    Irvine Labs, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

  61. Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc.

    Notice · published 2026-09-14 · comments close 2026-11-13 · Docket No. DEA-1759
    Drug Enforcement Administration, Justice Department · 2026-18753

    Cambrex High Point, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

  62. Emran Mohammad, RN, APRN, CNP; Decision and Order

    Notice · published 2026-09-11
    Drug Enforcement Administration, Justice Department · 2026-18605

  63. Joseph John Stubbers III, D.O.; Decision and Order

    Notice · published 2026-09-11
    Drug Enforcement Administration, Justice Department · 2026-18604

  64. Cheryl White, N.P.; Decision and Order

    Notice · published 2026-09-11
    Drug Enforcement Administration, Justice Department · 2026-18599

  65. Craig Cohen, DPM; Decision and Order

    Notice · published 2026-09-11
    Drug Enforcement Administration, Justice Department · 2026-18597